A strain of super-strong gonorrhea detected in the U.S. for the first time shows how vulnerable we are as antibiotics lose their punch @dmosbergen wsj.com/articles/new-s…
Gyms are seeing a shift away from HIIT. “You see fewer people trying to go all out, like level 10, and asking ‘where's the bucket?’ afterward.” on.wsj.com/3wH4wcB
“Superbugs,” or multidrug-resistant pathogens, could kill more than 10 million people a year by 2050 if new antibiotics aren’t developed, the World Health Organization says on.wsj.com/3Jp1kdk
The federal government should expand its oversight of risky research into pathogens, say biosecurity experts advising the government on.wsj.com/3HawceN
FDA advisers are backing annual Covid-19 boosters with some reservations about its rollout. A group of doctors and scientists has called for further studies to determine specifics of the plan. on.wsj.com/405yapi
CBD oils and other cannabis-derived products require closer regulation because of safety risks, the FDA said, as it seeks more authority from Congress on.wsj.com/3DgbhWg
New lawsuits ask federal courts to block state laws restricting access to abortion pills, the latest skirmish over the drugs since the Supreme Court overturned Roe v. Wade, @l_e_whyte reports wsj.com/articles/abort…
New lawsuits ask federal courts to block state laws restricting access to abortion pills, the latest skirmish over the drugs since the Supreme Court overturned Roe v. Wade on.wsj.com/3R8P42s
Health company Elevance, the parent of Blue Cross Blue Shield plans in 14 states, has agreed to buy Blue Cross and Blue Shield of Louisiana, which has almost 2 million members @annawmathews reports wsj.com/articles/eleva…
AmerisourceBergen, one of the biggest drug distributors in the U.S., is changing its name to Cencora as it expands globally and into new services, @arianapeca2 reports wsj.com/articles/drug-…
AmerisourceBergen, one of the biggest drug distributors in the U.S., is changing its name to Cencora as it expands globally and into new services on.wsj.com/3Hpc8Xc
Health company Elevance, the parent of Blue Cross Blue Shield plans in 14 states, has agreed to buy Blue Cross and Blue Shield of Louisiana, which has almost 2 million members on.wsj.com/3iZMLlv
Scientists said today that certain sea spiders can regenerate nearly half their body. Check out some of the many animals that can grow back lost body parts. Researchers study regrowth in these species, aiming to enhance human limb regeneration. wsj.com/story/photos-h…@WSJ
“My hands don’t work. I can’t even open a box.” High turnover among home caregivers is straining the daily lives of America’s aging population who rely on them to stay in their homes. wsj.com/articles/high-… via @WSJ
An annual immunization schedule, similar to the one for the flu, was part of changes the FDA recommended to simplify Covid-19 vaccinations and boosters on.wsj.com/3Dase4q
Researchers built surveillance networks around the country to track Covid-19 and monitor for variants. Now they are starting to leverage that system to search for other pathogens they had wanted to track through the sewers for years. on.wsj.com/3D5oam0
Breaking: Federal prosecutors are probing conduct at Abbott’s baby-formula plant in Michigan, which the company temporarily shutdown last year after a potentially deadly bacteria was found, @l_e_whyte, @davidamicand @jessenewman13 report wsj.com/articles/abbot…
Federal prosecutors are probing conduct at Abbott’s baby-formula plant in Michigan, which the company temporarily shutdown last year after a potentially deadly bacteria was found on.wsj.com/3ZPVozw
House Republicans plan to launch investigations into the NIH’s Covid-19 work, increasing scrutiny of the agency when it lacks key leadership @l_e_whyte reports wsj.com/articles/nih-f…
ICYMI: U.S. drug regulators rejected Eli Lilly's proposed new Alzheimer’s disease treatment, saying they need more data from clinical testing @Loftus reports wsj.com/articles/fda-s…
House Republicans plan to launch investigations into the NIH’s Covid-19 work, increasing scrutiny of the agency when it lacks key leadership on.wsj.com/3Hl7BoX
This week marks three years since the U.S. reported its first known Covid-19 case. Fewer people are dying from it but there’s room for improvement, public-health officials say. on.wsj.com/3wi1Guw
The FDA won’t approve Eli Lilly’s highly anticipated Alzheimer’s drug, because it wants more study data before making a decision, the company said on.wsj.com/3kuBKJp
The Centers for Medicare and Medicaid Services said it would take nursing homes’ use of antipsychotic medicines into account in ratings, to help prevent overprescribing and abuse on.wsj.com/3QWtga8
Party drug users say - at worst - they used to see someone pass out from dehydration at a club or festival. Fentanyl is changing that vibe.
“It used to just feel more innocent. It used to feel more fun.” wsj.com/articles/fenta…
Roughly one-fifth of children in the U.S. are considered obese. Families eager for new strategies are considering intermittent fasting. on.wsj.com/3krKUGg
Medical residents are joining unions, seeking better pay and working conditions. “When there’s extra work, the burden falls on us.” @dmosbergen reports wsj.com/articles/medic…
Drug companies may raise prices more than usual while high inflation gives them cover—and to get ahead of future U.S. controls via @JaredSHopkins wsj.com/articles/infla…
Johnson & Johnson is curtailing production of the Covid-19 vaccine as it faces a dispute with Merck and cancels manufacturing contracts on.wsj.com/3CLdaKx
David Kessler, the Biden administration official who steered the country’s Covid-19 vaccination and treatment efforts, plans to leave as the White House retools its approach to fighting the virus wsj.com/articles/key-c… via @WSJ